Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2009 - 2026)

Quest Diagnostics has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $146.0 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) rose 2.1% year-over-year to $146.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $580.0 million (up 6.81% YoY) and the FY2025 annual result came in at $570.0 million, up 15.62% from the prior year.
• Depreciation & Amortization (CF) fell to $146.0 million in Q2 2026 per DGX's latest filing, from $147.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $147.0 million in Q1 2026 and troughed at $106.0 million in Q1 2022.
• A 5-year average of $124.0 million and a median of $116.5 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) slipped 6.03% in 2023, then increased 23.85% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $116.0 million in 2022, then slipped by 6.03% to $109.0 million in 2023, then gained by 23.85% to $135.0 million in 2024, then rose by 7.41% to $145.0 million in 2025, then advanced by 0.69% to $146.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $146.0 million, $147.0 million, and $145.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.